Progressive External OphthalmoplegiaSymptoms, Doctors, Treatments, Advances & More
Learn About Progressive External Ophthalmoplegia
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
MN - Neuro
Margherita Milone is a Neurologist practicing medicine in Rochester, Minnesota. Dr. Milone is rated as an Elite provider by MediFind in the treatment of Progressive External Ophthalmoplegia. She is also highly rated in 36 other conditions, according to our data. Her clinical expertise encompasses Necrotizing Myopathy (NM), Progressive External Ophthalmoplegia, Nemaline Myopathy, and Tubular Aggregate Myopathy. Dr. Milone is board certified in MN State Medical License 2003-2023.
Truhlsen Eye Institute
Richard Legge is an Ophthalmologist practicing medicine in Omaha, Nebraska. He has been practicing medicine for over 40 years. Dr. Legge is rated as a Distinguished provider by MediFind in the treatment of Progressive External Ophthalmoplegia. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Optic Neuritis, Strabismus, Choroideremia, and Horizontal Gaze Palsy with Progressive Scoliosis.
CVS Pharmacy
Robert Taylor is a primary care provider, practicing in Internal Medicine in Mattapan, Massachusetts. Dr. Taylor is rated as an Elite provider by MediFind in the treatment of Progressive External Ophthalmoplegia. He is also highly rated in 41 other conditions, according to our data. His clinical expertise encompasses Progressive External Ophthalmoplegia, MELAS Syndrome, Lactic Acidosis, Cytochrome C Oxidase Deficiency, and Tissue Biopsy.
Summary: The North American Mitochondrial Disease Consortium (NAMDC) maintains a patient contact registry and tissue biorepository for patients with mitochondrial disorders.
Summary: Mitochondrial diseases are a genetically diverse group of disorders, some of which are caused by mutations or deletions in the mitochondrial DNA (mtDNA) and which display a wide range of severity and phenotypes. Despite a prevalence of roughly 1 in 8500 in the population there is no effective treatments for the majority of mitochondrial diseases beyond supportive care (Gorman 2016, Elliott 2008). ...